In‐utero exposure to tenofovir‐containing pre‐exposure prophylaxis and bone mineral content in HIV‐unexposed infants in South Africa
Kerusha Reddy, Kimesh L Naidoo, Carl Lombard, Zukiswa Godlwana, Alicia C Desmond, Richard Clark, James F Rooney, Glenda Gray, Dhayendre Moodley · 2024
Read In‐utero exposure to tenofovir‐containing pre‐exposure prophylaxis and bone mineral content in HIV‐unexposed infants in South Africa by Kerusha Reddy, Kimesh L Naidoo, Carl Lombard, Zukiswa Godlwana, Alicia C Desmond, Richard Clark, James F Rooney, Glenda Gray, Dhayendre Moodley (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11554427.txt.
Description
IntroductionTenofovir disoproxil fumarate (TDF) is a common drug of choice for pre‐exposure prophylaxis (PrEP) or as a combination HIV treatment for pregnant women. In‐utero exposure to TDF was found to be associated with lower bone mineral content (BMC) in HIV‐exposed uninfected neonates. Data for infants born to women taking TDF‐PrEP are lacking.
Catalog record
| CREATOR | Kerusha Reddy, Kimesh L Naidoo, Carl Lombard, Zukiswa Godlwana, Alicia C Desmond, Richard Clark, James F Rooney, Glenda Gray, Dhayendre Moodley |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |